Programme(s) to which this project applies: |
☑ MPhil/PhD | ☒ MRes[Med] | ☒ URIS |
From the perspectives of Chinese Medicine, integrative medicine and multidisciplinary approaches, the research will concentrate on clinical and experimental study for hard-to-cure diseases, such as cancer, diabetics, hepatic diseases, and renal diseases by using recently developed techniques in biomedical science, network pharmacology, OMICS, AI and other big data etc. The following are specific projects:
Professor YB Feng, School of Chinese Medicine
Professor Feng Yibin is currently a professor and Director of the School of Chinese Medicine, University of Hong Kong, and a member of the Chinese Pharmacopoeia Committee and members of HKSAR government committees related to Chinese Medicine. Mainly engaged in the research of integrated Chinese and Western medicine in the prevention and treatment of cancer and metabolic diseases. He has published more than 200 SCI papers. He also serves as editorial board members and reviewers for more than 70 international journals. Since 2017, according to the Essential Science Indicator (ESI), he has been listed as one of the world top 1% of Hong Kong University scholars for 6 consecutive years, and has also been listed as one of the top 2% of Stanford University scholars.
For more information or to express interest for this project, please email the supervisor or the specified contact point in the project description. Interested candidates are advised to enclose with your email:
Information on the research programme, funding support and admission documentations could be referenced online at the Research Postgraduate Admissions website. General admission enquiries should be directed to rpgmed@hku.hk.
HKUMed MBBS students interested in the Master of Research in Medicine (MRes[Med]) programme may visit the programme website for more information.
HKUMed UG students interested in the Undergraduate Research Internship Scheme (URIS) may visit the scheme’s website for more information.
Follow HKUMed